Michael H Brave

Publication Activity (10 Years)

Years Active: 2023-2024
Publications (10 Years): 4

Top Topics

Neoadjuvant Chemotherapy

Drug Administration

Top Venues

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Michael H Brave, William F Maguire, Chana Weinstock, Hui Zhang, Xin Gao, Fang Li, Jingyu Yu, Wentao Fu, Hong Zhao, William F Pierce, Elaine Chang, Jeannette Dinin, Mallorie H Fiero, Nam Atiqur Rahman, Shenghui Tang, Richard Pazdur, Paul G Kluetz, Laleh Amiri-Kordestani, Daniel L Suzman
FDA Approval Summary: Enfortumab Vedotin Plus Pembrolizumab for Locally Advanced or Metastatic Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
Jaleh Fallah, Chana Weinstock, Gautam U Mehta, Michael H Brave, William F Pierce, Richard Pazdur, Abhilasha Nair, Daniel L Suzman, Laleh Amiri-Kordestani
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Jaleh Fallah, Chana Weinstock, Gautam U Mehta, Michael H Brave, William F Pierce, Richard Pazdur, Abhilasha Nair, Daniel L Suzman, Laleh Amiri-Kordestani
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)
Jaleh Fallah, Chana Weinstock, Gautam U Mehta, Michael H Brave, William F Pierce, Richard Pazdur, Abhilasha Nair, Daniel L Suzman, Laleh Amiri-Kordestani
FDA Approval Summary: Belzutifan for VHL Disease Tumors-Response. Clinical cancer research : an official journal of the American Association for Cancer Research 29 (3) (2023)